Pioneering localization of dialysis for patients
The philosophy of Boryung Pharmaceutical of ‘a company contributing to the human health’ is directly applied to dialysis project. Boryung Pharmaceutical entered the field of dialysis in 1990. At that time, patients had great pains during continuous ambulatory peritoneal dialysis (CAPD) since the medical technology was not developed, and they were suffering from long period of treatment and expensive costs. As a lot of money and time was required in R&D of dialysis project, domestic pharmaceutical companies weren’t very interested in this field. However, Boryung Pharmaceutical engaged in this project without clinging to the profits. The company relieved the pains of dialysis patients by successfully making localization of dialysate for the first time in Korea. Dialysis project of Boryung Pharmaceutical presented reasonable costs for drug, creating an opportunity to make new change in dialysis industry in Korea.